{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:38:40Z","timestamp":1792798720580,"version":"4.5.0"},"reference-count":29,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Air Force Medical University Partner Laboratory Collaboration and Exchange Program","award":["2023HB011"],"award-info":[{"award-number":["2023HB011"]}],"id":[{"id":"https:\/\/ror.org\/00ms48f15","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shaanxi Province Health and Wellness Central Nervous System Disease Research and Innovation Platform","award":["2023PT-05"],"award-info":[{"award-number":["2023PT-05"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322023, 82101364, 82122021, 82320108007"],"award-info":[{"award-number":["82322023, 82101364, 82122021, 82320108007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Scholar","award":["097"],"award-info":[{"award-number":["097"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2024,12,17]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stroke-induced transient immune suppression is believed to contribute to post-stroke infections. The \u03b2-adrenergic receptor antagonist, propranolol, has been shown to prevent stroke-associated pneumonia (SAP) via reversing post-stroke immunosuppression in preclinical studies and in retrospective analysis in stroke patients. However, whether propranolol can reduce the risk of SAP has not been tested in prospective, randomised controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To describe the rationale and design of a multicentre, prospective, open-label, endpoint-blinded, randomised controlled study to evaluate the safety and efficacy of propranolol hydrochloride injection for the prevention of SAP in patients with intracerebral haemorrhage (ICH) (PROCHASE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In this investigator-initiated trial, we compare the safety of the standard medical treatment to standard medical treatment plus intravenous propranolol hydrochloride administration (5\u2009mg daily on days 1\u20137) in patients with ICH and the efficacy of this intervention to reduce the occurrence of SAP. All patients will be followed up for 90\u00b17\u2009days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study outcomes<\/jats:title>\n                    <jats:p>The primary efficacy outcome is SAP within 7\u00b11\u2009days diagnosed by the defined algorithm based on a diagnosis of SAP recommendations from the pneumonia in stroke consensus group. The primary safety outcome is defined as severe or moderate bradycardia within 7\u00b11\u2009days. The secondary outcome is a modified Rankin score of 0\u20133 at 90\u00b17\u2009days after randomisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The PROCHASE trial aims to generate clinical evidence regarding the safety and efficacy of propranolol in preventing SAP in patients with ICH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/svn-2024-003630","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T10:35:36Z","timestamp":1735641336000},"page":"520-525","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebral haemorrhage (PROCHASE): rationale and design"],"prefix":"10.1136","volume":"10","author":[{"given":"Bin","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunnan","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tangdu Hospital Fourth Military Medical University, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Liesz","sequence":"additional","affiliation":[{"name":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"name":"Munich Cluster for Systems Neurology (SyNergy), Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-5342","authenticated-orcid":false,"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[{"name":"Department of Neurology with Experimental Neurology, Neuroscience Clinical Research Center, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-7390","authenticated-orcid":false,"given":"Yan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tangdu Hospital Fourth Military Medical University, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-5147","authenticated-orcid":false,"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-4637","authenticated-orcid":false,"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2025082602100705000_10.4.520.1","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-11-110","article-title":"Post-stroke infection: a systematic review and meta-analysis","volume":"11","author":"Westendorp","year":"2011","journal-title":"BMC Neurol"},{"key":"2025082602100705000_10.4.520.2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1747493018806196","article-title":"Frequency of post-stroke pneumonia: Systematic review and meta-analysis of observational studies","volume":"14","author":"Badve","year":"2019","journal-title":"Int J Stroke"},{"key":"2025082602100705000_10.4.520.3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0b013e31823152b1","article-title":"Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke","volume":"77","author":"Finlayson","year":"2011","journal-title":"Neurology (ECronicon)"},{"key":"2025082602100705000_10.4.520.4","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000269"},{"key":"2025082602100705000_10.4.520.5","article-title":"Antibiotic therapy for preventing infections in patients with acute stroke","volume":"1","author":"Westendorp","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082602100705000_10.4.520.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00126-9"},{"key":"2025082602100705000_10.4.520.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62456-9"},{"key":"2025082602100705000_10.4.520.8","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2017-000123"},{"key":"2025082602100705000_10.4.520.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.144"},{"key":"2025082602100705000_10.4.520.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.02.015"},{"key":"2025082602100705000_10.4.520.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1112454"},{"key":"2025082602100705000_10.4.520.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1765"},{"key":"2025082602100705000_10.4.520.13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021098"},{"key":"2025082602100705000_10.4.520.14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4194"},{"key":"2025082602100705000_10.4.520.15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1210301"},{"key":"2025082602100705000_10.4.520.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.10.007"},{"key":"2025082602100705000_10.4.520.17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10072-017-2877-x","article-title":"Increased infections with \u03b2-blocker use in ischemic stroke, a \u03b22-receptor mediated process?","volume":"38","author":"Starr","year":"2017","journal-title":"Neurol Sci"},{"key":"2025082602100705000_10.4.520.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1210-y"},{"key":"2025082602100705000_10.4.520.19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.008260"},{"key":"2025082602100705000_10.4.520.20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-78-6-913","article-title":"Propranolol","volume":"78","author":"Morrelli","year":"1973","journal-title":"Ann Intern Med"},{"key":"2025082602100705000_10.4.520.21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1389557515666151016125948","article-title":"Beta-Blockers: Current State of Knowledge and Perspectives","volume":"16","author":"Ogrodowczyk","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"2025082602100705000_10.4.520.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.1.6"},{"key":"2025082602100705000_10.4.520.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"2025082602100705000_10.4.520.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441907"},{"key":"2025082602100705000_10.4.520.25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009617"},{"key":"2025082602100705000_10.4.520.26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(22)00010-2","article-title":"Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial","volume":"21","author":"Zhao","year":"2022","journal-title":"Lancet Neurol"},{"key":"2025082602100705000_10.4.520.27","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.122.038867"},{"key":"2025082602100705000_10.4.520.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6624.737"},{"key":"2025082602100705000_10.4.520.29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5853\/jos.2018.03251","article-title":"Chest Computed Tomography Findings and Validation of Clinical Criteria of Stroke Associated Pneumonia","volume":"21","author":"Zapata-Arriaza","year":"2019","journal-title":"J Stroke"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2024-003630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:10:19Z","timestamp":1756199419000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2024-003630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/svn-2024-003630"],"URL":"https:\/\/doi.org\/10.1136\/svn-2024-003630","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}